StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
693
This month
6
This week
1
This year
39
Yesterday
1
Publishing Date
2023 - 12 - 08
4
2023 - 10 - 15
3
2023 - 06 - 12
3
2023 - 05 - 25
3
2023 - 05 - 02
3
2023 - 04 - 04
3
2023 - 01 - 30
3
2023 - 01 - 25
3
2022 - 12 - 22
3
2022 - 12 - 09
3
2022 - 12 - 01
3
2022 - 11 - 08
3
2022 - 11 - 02
3
2022 - 09 - 28
3
2022 - 08 - 25
3
2022 - 08 - 22
3
2022 - 08 - 18
3
2022 - 08 - 08
3
2022 - 07 - 28
3
2022 - 07 - 20
3
2022 - 06 - 27
3
2022 - 06 - 06
3
2022 - 05 - 24
3
2022 - 04 - 26
3
2022 - 03 - 29
4
2022 - 03 - 01
3
2022 - 01 - 05
3
2021 - 11 - 17
4
2021 - 11 - 09
5
2021 - 11 - 02
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 09 - 28
6
2021 - 08 - 13
3
2021 - 08 - 12
3
2021 - 08 - 05
4
2021 - 07 - 23
4
2021 - 07 - 19
3
2021 - 06 - 24
4
2021 - 06 - 21
3
2021 - 06 - 16
3
2021 - 06 - 09
3
2021 - 05 - 20
4
2021 - 05 - 04
3
2021 - 04 - 28
3
2021 - 04 - 22
3
2021 - 03 - 25
2
2021 - 03 - 23
2
2021 - 03 - 19
4
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 10
2
2021 - 03 - 08
2
2021 - 02 - 17
3
2021 - 01 - 12
2
2021 - 01 - 08
2
2020 - 12 - 28
2
2020 - 12 - 23
3
2020 - 12 - 21
2
2020 - 12 - 11
2
Sector
Commercial services
3
Communications
30
Consumer durables
3
Consumer non-durables
7
Consumer services
1
Distribution services
2
Electronic technology
6
Finance
11
Health services
3
Health technology
693
Industrial services
2
Manufacturing
44
N/a
14
Process industries
7
Producer manufacturing
3
Professional, scientific, and technical services
11
Retail trade
2
Technology services
4
Tags
Acquisition
9
Active
10
Antiviral
10
Application
24
Approval
31
Authorization
14
Breast
12
Cancer
66
Candidate
16
Children
18
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
15
Collaboration
21
Comirnaty®
10
Conference
18
Covid
58
Covid-19
41
Disease
28
Drug
54
Earnings
20
Ema
10
Emergency use authorization
10
Europe
13
Events
12
Expected
10
Fda
74
Fda-approvals
14
Financial
19
Global
56
Growth
29
Hiv
15
Hormone
10
License
19
Market
100
Merge
15
N/a
432
Order
15
People
24
Pharm-country
34
Pharmaceutical
17
Phase 2
12
Phase 3
21
Positive
45
Potential
11
Product-news
10
Regulatory
12
Report
49
Research
51
Respiratory
10
Results
62
Risk
16
Study
20
Therapeutics
40
Therapy
29
Topline
14
Treatment
74
Trial
47
Ulcerative colitis
12
Update
14
Vaccine
106
Entities
Abbott laboratories
32
Abbvie inc.
37
Adc therapeutics sa
5
Aerie pharmaceuticals, inc.
5
Agios pharmaceuticals, inc.
10
Alkermes plc
4
Alnylam pharmaceuticals, inc.
14
Amgen inc.
34
Arvinas, inc.
24
Astellas pharma inc
26
Astrazeneca plc
45
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
5
Baxter international inc.
6
Beam therapeutics inc.
6
Becton, dickinson and company
6
Beigene, ltd.
10
Biocryst pharmaceuticals, inc.
14
Biohaven pharmaceutical holding company ltd.
15
Biomarin pharmaceutical inc.
4
Biontech se
95
Blueprint medicines corporation
10
Bristol-myers squibb company
61
Clovis oncology, inc.
11
Eli lilly and company
80
Endo international plc
7
Epizyme, inc.
11
Exelixis, inc.
13
Genmab a/s
4
Gilead sciences, inc.
27
Glaxosmithkline plc
64
Global blood therapeutics, inc.
6
Ideaya biosciences, inc.
4
Illumina, inc.
12
Incyte corporation
14
Ionis pharmaceuticals, inc.
5
Johnson & johnson
76
Karyopharm therapeutics inc.
10
Moderna, inc.
7
Morgan stanley
4
Myovant sciences ltd.
14
Neurocrine biosciences, inc.
4
Novartis ag
88
Novo nordisk a/s
11
Omeros corporation
13
Opko health, inc.
6
Orange
29
Otonomy, inc.
13
Pfizer, inc.
693
Regeneron pharmaceuticals, inc.
22
Rigel pharmaceuticals, inc.
11
Sanofi
153
Seagen inc.
7
Takeda pharmaceutical company limited
23
Teva pharmaceutical industries ltd
29
Verastem, inc.
10
Viatris inc.
8
Voyager therapeutics, inc.
6
Xeris pharmaceuticals, inc.
10
Y-mabs therapeutics, inc.
10
Symbols
AAPL
546
ABB
1433
ABBV
1029
ABLZF
1172
ABT
1795
ACN
602
ARVL
590
BDX
796
BMO
539
BMY
662
BNPQF
654
BNPQY
654
BSX
576
CMI
542
CSCO
532
DELL
579
DHR
786
DOW
556
DUK
528
ERIC
547
F
643
FNCTF
1402
GE
918
GLAXF
660
GOOG
784
GOOGL
785
GSK
887
HON
1791
HUBS
1400
IBM
655
IT
595
JNJ
4591
LLY
1710
LMT
576
LYV
717
MDT
1285
MMM
938
MS
4289
MSFT
808
MT
591
NOC
589
NOK
902
NOKBF
907
NVO
634
NVS
1243
NVSEF
1033
ORCL
1160
PFE
693
PHG
963
SAP
1480
SAPGF
1234
SNOW
796
SNY
1634
SNYNF
1305
STLA
535
SYK
536
TMO
1626
TRU
533
VZ
1218
XYF
678
Exchanges
Amex
5
Nasdaq
423
Nyse
693
Crawled Date
2024 - 02 - 27
3
2023 - 12 - 08
4
2023 - 10 - 16
5
2023 - 06 - 12
3
2023 - 05 - 25
3
2023 - 05 - 02
3
2023 - 04 - 04
3
2023 - 01 - 25
3
2022 - 12 - 22
3
2022 - 12 - 01
3
2022 - 11 - 08
3
2022 - 09 - 28
3
2022 - 08 - 25
3
2022 - 08 - 22
3
2022 - 08 - 18
3
2022 - 08 - 08
3
2022 - 07 - 28
3
2022 - 07 - 20
3
2022 - 06 - 27
3
2022 - 06 - 06
3
2022 - 05 - 24
3
2022 - 04 - 26
3
2022 - 03 - 29
3
2022 - 03 - 01
3
2022 - 01 - 05
3
2021 - 11 - 17
4
2021 - 11 - 09
5
2021 - 11 - 02
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 09 - 28
6
2021 - 08 - 13
3
2021 - 08 - 12
3
2021 - 08 - 05
4
2021 - 07 - 23
3
2021 - 07 - 19
3
2021 - 06 - 24
4
2021 - 06 - 16
3
2021 - 06 - 09
3
2021 - 05 - 20
4
2021 - 05 - 04
3
2021 - 04 - 28
3
2021 - 04 - 22
3
2021 - 04 - 13
3
2021 - 04 - 01
2
2021 - 03 - 31
2
2021 - 03 - 26
2
2021 - 03 - 25
2
2021 - 03 - 23
2
2021 - 03 - 19
4
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 10
2
2021 - 03 - 08
2
2021 - 02 - 17
3
2021 - 01 - 12
2
2020 - 12 - 28
2
2020 - 12 - 23
3
2020 - 12 - 21
2
2020 - 12 - 11
3
Crawled Time
00:00
25
00:01
1
00:20
4
01:00
15
02:00
6
03:00
1
04:00
4
04:20
1
05:00
9
05:03
1
05:10
1
06:00
8
06:03
2
07:00
10
08:00
3
08:20
3
09:00
11
09:01
1
10:00
16
10:51
1
11:00
66
11:01
1
12:00
90
12:03
1
12:15
4
12:20
16
12:30
12
12:34
1
13:00
45
13:01
1
13:07
1
13:14
1
13:15
3
13:17
1
13:20
6
13:27
1
13:30
6
13:50
1
13:55
1
14:00
39
14:03
1
14:15
2
14:20
5
14:30
1
15:00
34
15:15
3
15:20
9
15:21
1
15:28
1
15:30
4
16:00
39
16:20
2
17:00
27
18:00
23
18:31
2
19:00
20
20:00
17
21:00
27
22:00
26
23:00
14
Source
ir.akerotx.com
2
ir.vaccinex.com
1
ir.voyagertherapeutics.com
3
mindmed.co
1
www.4dpharmaplc.com
1
www.achievelifesciences.com
2
www.biospace.com
261
www.chi-med.com
1
www.eyenoviabio.com
1
www.fda.gov
31
www.globenewswire.com
147
www.prnewswire.com
242
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
PFE
exchanges :
Nyse
save search
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Published:
2024-04-22
(Crawled : 14:00)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
1.0%
|
O:
0.0%
H:
1.92%
C:
1.0%
emblaveo
treatment
for
infections
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
Published:
2024-04-11
(Crawled : 20:00)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-0.23%
|
O:
0.11%
H:
0.38%
C:
-0.04%
meeting
NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects
Published:
2024-04-09
(Crawled : 18:00)
- prnewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-1.94%
|
O:
-0.97%
H:
0.26%
C:
-0.75%
for
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Published:
2024-04-09
(Crawled : 12:00)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-1.11%
|
O:
0.73%
H:
2.49%
C:
0.11%
abrysvo
disease
positive
risk
for
rsv
results
study
ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager
Published:
2024-04-08
(Crawled : 17:00)
- prnewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-1.5%
|
O:
-0.39%
H:
0.0%
C:
0.0%
DOW
|
$56.99
0.58%
-0.02%
3.2M
|
Process Industries
|
-4.52%
|
O:
0.44%
H:
0.4%
C:
-0.72%
dean
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published:
2024-04-08
(Crawled : 13:30)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-1.5%
|
O:
-0.39%
H:
0.0%
C:
0.0%
fda
approval
for
hiv
living
Bluerock Value Exchange Fully Subscribes $46.5 Million Diversified Industrial Portfolio I DST
Published:
2024-03-27
(Crawled : 13:00)
- prnewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-4.82%
|
O:
0.43%
H:
0.81%
C:
0.25%
million
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Published:
2024-03-26
(Crawled : 21:00)
- globenewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-4.82%
|
O:
0.43%
H:
0.81%
C:
0.25%
therapeutics
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
Published:
2024-03-19
(Crawled : 11:00)
- globenewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-5.27%
|
O:
-0.18%
H:
0.4%
C:
-0.14%
pharmaceuticals
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
Published:
2024-03-18
(Crawled : 21:00)
- globenewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-5.27%
|
O:
-0.18%
H:
0.4%
C:
-0.14%
ARVN
|
$34.9
0.52%
0.54%
850K
|
Health Technology
|
-18.08%
|
O:
-3.22%
H:
4.58%
C:
3.23%
medical
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
Published:
2024-03-13
(Crawled : 11:00)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-6.25%
|
O:
1.0%
H:
1.41%
C:
-0.25%
disease
pneumococcal
children
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Published:
2024-03-12
(Crawled : 12:30)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-7.44%
|
O:
-0.21%
H:
0.11%
C:
-1.06%
adcetris
positive
trial
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published:
2024-03-12
(Crawled : 12:00)
- globenewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-7.44%
|
O:
-0.21%
H:
0.11%
C:
-1.06%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
-0.41%
|
O:
0.9%
H:
2.03%
C:
1.89%
VERU
|
$1.27
-3.05%
-3.15%
1.3M
|
Health Technology
|
93.01%
|
O:
-0.53%
H:
2.22%
C:
-3.59%
ALT
|
$7.47
8.1%
7.62%
2M
|
Commercial Services
|
-24.32%
|
O:
0.3%
H:
11.41%
C:
9.8%
medical
program
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published:
2024-03-07
(Crawled : 12:00)
- prnewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-3.42%
|
O:
0.04%
H:
0.44%
C:
-1.51%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-7.67%
|
O:
-2.08%
H:
0.13%
C:
-0.57%
BMY
|
$49.14
0.43%
0.2%
6.4M
|
Health Technology
|
-7.94%
|
O:
0.36%
H:
0.34%
C:
-0.54%
XFOR
|
$1.36
7.94%
6.67%
2.3M
|
Health Technology
|
41.15%
|
O:
0.12%
H:
0.0%
C:
-4.98%
EYPT
|
News
|
$16.95
-3.97%
-3.95%
1.3M
|
Health Technology
|
-34.15%
|
O:
2.56%
H:
1.37%
C:
-4.13%
AQST
|
$4.38
6.7%
6.39%
1.7M
|
Health Technology
|
-12.92%
|
O:
1.79%
H:
12.3%
C:
10.94%
ALKS
|
$24.07
0.92%
0.87%
1.2M
|
Health Technology
|
-16.83%
|
O:
1.11%
H:
0.96%
C:
0.65%
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024
Published:
2024-03-06
(Crawled : 01:00)
- prnewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
0.69%
|
O:
3.14%
H:
1.49%
C:
1.08%
KZR
|
$0.822
4.05%
3.92%
710K
|
Health Technology
|
-20.39%
|
O:
1.94%
H:
0.0%
C:
-1.9%
financial
results
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference - March 5, 2024
Published:
2024-03-05
(Crawled : 16:00)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
1.43%
|
O:
-0.08%
H:
2.13%
C:
0.81%
conference
ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses
Published:
2024-03-04
(Crawled : 21:00)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-1.24%
|
O:
-1.09%
H:
0.61%
C:
-1.56%
trial
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
Published:
2024-02-29
(Crawled : 16:00)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-2.88%
|
O:
0.11%
H:
0.44%
C:
-1.88%
abrysvo
positive
rsv
Kalderos Attracts Two Recognized Industry Leaders to Board of Directors
Published:
2024-02-27
(Crawled : 14:00)
- prnewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-3.38%
|
O:
-0.22%
H:
0.29%
C:
-0.85%
leaders
Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-02-27
(Crawled : 12:00)
- globenewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-3.38%
|
O:
-0.22%
H:
0.29%
C:
-0.85%
ARVN
|
$34.9
0.52%
0.54%
850K
|
Health Technology
|
-28.47%
|
O:
0.0%
H:
1.25%
C:
-1.6%
year
update
financial
results
← Previous
1
2
3
4
5
6
7
8
9
…
34
35
Next →
Gainers vs Losers
74%
26%
Top 10 Gainers
MTTR
|
News
M
|
$4.8
175.86%
63.6%
71M
|
AGBA
|
$2.5
100.0%
56.6%
200M
|
Finance
MLEC
|
$2.47
76.43%
42.62%
78M
|
n/a
NUWE
|
$0.334
29.96%
40.99%
2.5M
|
Manufacturing
EDBL
|
News
|
$6.26
66.49%
40.13%
16M
|
ATGL
|
$2.86
46.25%
32.8%
180K
|
VIVK
|
$1.43
33.65%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.7M
|
SDIG
A
|
$3.64
35.32%
26.0%
990K
|
PROK
|
$2.72
33.33%
24.58%
2.6M
|
Your saved searches
Save your searches and get alerts when important news are released.